NAMS position history
The shares of Newamsterdam Pharma (NAMS) that Duquesne Family Office LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q3: 287,535 shares, $4.8M, 0.16% of portfolio, New
- 2024 Q4: 287,535 shares, $7.4M, 0.20% of portfolio
- 2025 Q1: 800,360 shares, $16M, 0.54% of portfolio, Add +178.4%
- 2025 Q2: 832,175 shares, $15M, 0.37% of portfolio, Add +4.0%
- 2025 Q3: 1,923,700 shares, $55M, 1.3% of portfolio, Add +131.2%
- 2025 Q4: 3,070,146 shares, $108M, 2.4% of portfolio, Add +59.6%
- 2026 Q1: 3,070,146 shares, $98M, 2.9% of portfolio
- 2026 Q2: 3,070,146 shares, $104M, 2.0% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|